WebApr 13, 2024 · Inclusion Criteria: Signed informed consent obtained prior to initiation of any study-specific procedures and treatment; Previously treated, pathologically confirmed, locally advanced or metastatic solid tumors with measurable disease for which cisplatin is a reasonable treatment option, including, but not limited to, non-small cell lung, … WebCisplatin for injection is a highly emetogenic antineoplastic agent; premedicate with anti-emetic agents; without antiemetic therapy, marked nausea and vomiting occur in almost all patients treated...
Patient Consent Form
WebFeb 16, 2024 · Generic name: cisplatin [ sis-PLA-tin ] Brand names: Platinol, Platinol-AQ, Platinol (Restricted Access) Dosage forms: intravenous powder for injection (50 mg), … WebDescription; ABSTRACT. Background: The aim of this study is to evaluate the current state of ototoxicity monitoring for patients receiving cisplatin chemotherapy in an academic medical center with particular attention to how closely monitoring adheres to national ototoxicity guidelines.. Methods: Case series including retrospective medical records … changing data type in salesforce
Carboplatin and etoposide - Cancer Research UK
WebCisplatin is a chemotherapy drug used to treat testicular, ovarian, bladder, head and neck, lung and cervical cancer. It may also be used to treat other cancers. It is best to read this … WebAbstract Cisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. ... Shanghai, China) using a 25-gauge needle. After allowing tumors to form for 10 days, 5 mg/kg/d of the nano-zinc carrier-AM-USP14 siRNA complex was introduced via the tail vein for ... WebJul 12, 2024 · Patients received either nab-paclitaxel (nab-paclitaxel 125 mg/m 2 on days 1 and 8; cisplatin 75 mg/m² on day 1) or gemcitabine plus cisplatin (gemcitabine 1250 mg/m² on days 1 and 8; cisplatin ... haringey council blue badge application form